Dakota Jenneman, DO
Hematology & Oncology · Lafayette, LANPI 1356846778
Payments from drug & device makers
Across 73 payments — averaging $40.67 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Merck$1K
- Beone Medicines USA, Inc.$242
- Johnson & Johnson$234
- Regeneron Healthcare Solutions, Inc.$142
- Daiichi Sankyo Inc.$110
- Novartis$109
- plus $1K from 25 others
What the payments were for
- Grants$1,00034%
- Food & beverage$1,96966%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Merck | 5 | $1,083 |
| Beone Medicines USA, Inc. | 4 | $242 |
| Johnson & Johnson | 6 | $234 |
| Regeneron Healthcare Solutions, Inc. | 2 | $142 |
| Daiichi Sankyo Inc. | 5 | $110 |
| Novartis | 5 | $109 |
| Exelixis Inc. | 1 | $97 |
| AstraZeneca(2 entities) | 5 | $90 |
| Novocure Inc. | 1 | $81 |
| AbbVie | 4 | $75 |
| Geron Corporation | 3 | $73 |
| Pfizer | 4 | $73 |
| Incyte Corporation | 3 | $64 |
| Jazz Pharmaceuticals Inc. | 2 | $52 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $46 |
| Astellas Pharma US Inc | 2 | $42 |
| Sanofi | 2 | $34 |
| E.r. Squibb & Sons, L.L.C. | 2 | $34 |
| AVEO Pharmaceuticals, Inc. | 2 | $33 |
| Bayer | 2 | $32 |
| Servier Pharmaceuticals LLC | 1 | $29 |
| Sobi, Inc | 1 | $27 |
| Springworks Therapeutics, Inc. | 1 | $25 |
| Legend Biotech USA Inc. | 1 | $21 |
| Pharmaessentia USA Corporation | 1 | $20 |
| Cumberland Pharmaceuticals, Inc. | 1 | $19 |
| Pharmacosmos Therapeutics Inc. | 1 | $18 |
| Genentech USA, Inc. | 1 | $18 |
| Rigel Pharmaceuticals, Inc. | 1 | $17 |
| Karyopharm Therapeutics Inc. | 1 | $16 |
| Bristol Myers Squibb | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,969 in reported general payments places this provider in the 30th percentile of 183 hematology & oncology providers in Louisiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ondansetron Hcl | 16 | $76 |
| Prochlorperazine Maleate | 12 | $67 |
Paid to pharmacies, not to this prescriber.
Other hematology & oncology in Lafayette
- Chancellor DonaldLafayette$60K
- Marc MatranaNew Orleans$4.6M
- Pedro BarataNew Orleans$4.2M
- Hana SafahBaton Rouge$3.8M
- Nakhle SabaBaton Rouge$2.4M
- Victor LinBaton Rouge$2.3M
- Marshall StaggBaton Rouge$1.6M
- Carter DavisNew Orleans$1.6M
- Maissaa JanbainNew Orleans$1.5M
- David OubreHammond$1.4M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.